Trial Profile
Multicenter phase I trial of the preoperative UFT/LV medical treatment and radiotherapy for the resectable T3 and T2N1-2 rectum cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary)
- Indications Rectal cancer
- Focus Adverse reactions
- 06 Feb 2010 New trial record